Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-12-31

FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Archis Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for nicardipine hydrochloride from Archis Pharma LLC, approving the generic product under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine hydrochloride (Nicardipine)

Snippet

SUPPL AP for NICARDIPINE HYDROCHLORIDE (NICARDIPINE HYDROCHLORIDE)